These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


304 related items for PubMed ID: 9107082

  • 1. Mobilization and collection of PBSC in healthy donors: a retrospective analysis of the Italian Bone Marrow Transplantation Group (GITMO).
    Majolino I, Cavallaro AM, Bacigalupo A, Rambaldi A, Falda M, Locatelli F, Raimondi R, Pucci G, Mordini N, Barbui T, Locatelli F, Rodeghiero F, Irrera G, Indovina A, Valbonesi M, Bellavita P, Tassi V, Perotti C, Soli M, Bresolin G.
    Haematologica; 1997; 82(1):47-52. PubMed ID: 9107082
    [Abstract] [Full Text] [Related]

  • 2. Treatment of normal donors with rhG-CSF 16 micrograms/kg for mobilization of peripheral blood stem cells and their apheretic collection for allogeneic transplantation.
    Majolino I, Buscemi F, Scimé R, Indovina A, Santoro A, Vasta S, Pampinella M, Catania P, Fiandaca T, Caronia F.
    Haematologica; 1995; 80(3):219-26. PubMed ID: 7545635
    [Abstract] [Full Text] [Related]

  • 3. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I, Cepulić BG, Mazić S.
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [Abstract] [Full Text] [Related]

  • 4. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation.
    Sohn SK, Kim JG, Seo KW, Chae YS, Jung JT, Suh JS, Lee KB.
    Bone Marrow Transplant; 2002 Jul; 30(2):81-6. PubMed ID: 12132046
    [Abstract] [Full Text] [Related]

  • 5. Peripheral blood stem cell apheresis for allogeneic transplants: Ibni Sina experience.
    Arat M, Arslan O, Ayyildiz E, Topcuoglu P, Dalva K, Ilhan O.
    Transfus Apher Sci; 2004 Jun; 30(3):189-91. PubMed ID: 15172622
    [Abstract] [Full Text] [Related]

  • 6. Single-dose pegfilgrastim for the mobilization of allogeneic CD34+ peripheral blood progenitor cells in healthy family and unrelated donors.
    Kroschinsky F, Hölig K, Poppe-Thiede K, Zimmer K, Ordemann R, Blechschmidt M, Oelschlaegel U, Bornhauser M, Rall G, Rutt C, Ehninger G.
    Haematologica; 2005 Dec; 90(12):1665-71. PubMed ID: 16330441
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Acceptance and feasibility of peripheral stem cell mobilisation compared to bone marrow collection from healthy unrelated donors.
    Ordemann R, Hölig K, Wagner K, Rautenberg U, Bornhäuser M, Kroschinsky F, Schäfer J, Schuler U, Ehninger G.
    Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S25-8. PubMed ID: 9712488
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy and toxicity of a high-dose G-CSF schedule for peripheral blood progenitor cell mobilization in healthy donors.
    Martínez C, Urbano-Ispizua A, Marín P, Merino A, Rovira M, Carreras E, Montserrat E.
    Bone Marrow Transplant; 1999 Dec; 24(12):1273-8. PubMed ID: 10627634
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantation.
    Körbling M, Anderlini P, Durett A, Maadani F, Bojko P, Seong D, Giralt S, Khouri I, Andersson B, Mehra R, vanBesien K, Mirza N, Przepiorka D, Champlin R.
    Bone Marrow Transplant; 1996 Dec; 18(6):1073-9. PubMed ID: 8971375
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The feasibility of peripheral blood stem cell collection for autograft following failure in bone marrow aspiration.
    Lefrère F, Hermine O, Audat F, Buzyn A, Cavazzana-Calvo M, Boccaccio C, Varet B.
    Hematol Cell Ther; 1998 Jun; 40(3):133-7. PubMed ID: 9698222
    [Abstract] [Full Text] [Related]

  • 19. Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation.
    Singhal S, Powles R, Kulkarni S, Treleaven J, Sirohi B, Millar B, Shepherd V, Saso R, Rowland A, Long S, Cabral S, Horton C, Mehta J.
    Bone Marrow Transplant; 2000 Mar; 25(5):501-5. PubMed ID: 10713626
    [Abstract] [Full Text] [Related]

  • 20. Blood stem cell collection using chemotherapy with or without systematic G-CSF: experience in 52 patients with multiple myeloma.
    Lefrere F, Makke J, Fermand J, Marolleau J, Dal Cortivo L, Alberti C, Mouton V, Benbunan M, Miclea J.
    Bone Marrow Transplant; 1999 Sep; 24(5):463-6. PubMed ID: 10482928
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.